SG1D1_HUMAN - dbPTM
SG1D1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SG1D1_HUMAN
UniProt AC O95968
Protein Name Secretoglobin family 1D member 1
Gene Name SCGB1D1
Organism Homo sapiens (Human).
Sequence Length 90
Subcellular Localization Secreted .
Protein Description May bind androgens and other steroids, may also bind estramustine, a chemotherapeutic agent used for prostate cancer. May be under transcriptional regulation of steroid hormones..
Protein Sequence MRLSVCLLLLTLALCCYRANAVVCQALGSEITGFLLAGKPVFKFQLAKFKAPLEAVAAKMEVKKCVDTMAYEKRVLITKTLGKIAEKCDR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
71PhosphorylationKCVDTMAYEKRVLIT
HHHHHHHHHHHHHHH
15.9122817900

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SG1D1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SG1D1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SG1D1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LIFR_HUMANLIFRphysical
28514442
VWDE_HUMANVWDEphysical
28514442
SEM4D_HUMANSEMA4Dphysical
28514442
CNTP3_HUMANCNTNAP3physical
28514442
ITA3_HUMANITGA3physical
28514442
PLXA2_HUMANPLXNA2physical
28514442
LEPR_HUMANLEPRphysical
28514442
GPR98_HUMANGPR98physical
28514442
SE1L3_HUMANSEL1L3physical
28514442
CSTN1_HUMANCLSTN1physical
28514442
ADA21_HUMANADAM21physical
28514442
CD109_HUMANCD109physical
28514442
SEM4G_HUMANSEMA4Gphysical
28514442
SUSD1_HUMANSUSD1physical
28514442
MKS3_HUMANTMEM67physical
28514442
MANBA_HUMANMANBAphysical
28514442
ISCA1_HUMANISCA1physical
28514442
MICA_HUMANMICAphysical
28514442
CBPE_HUMANCPEphysical
28514442
INSR_HUMANINSRphysical
28514442
ARSK_HUMANARSKphysical
28514442
ITA2_HUMANITGA2physical
28514442
SYAM_HUMANAARS2physical
28514442
CHLE_HUMANBCHEphysical
28514442
FREM2_HUMANFREM2physical
28514442
EMC10_HUMANEMC10physical
28514442
PGAP1_HUMANPGAP1physical
28514442
EMC3_HUMANEMC3physical
28514442
GT253_HUMANCERCAMphysical
28514442
PLXA3_HUMANPLXNA3physical
28514442
LRP1B_HUMANLRP1Bphysical
28514442
CA2D1_HUMANCACNA2D1physical
28514442
MOXD1_HUMANMOXD1physical
28514442
EPDR1_HUMANEPDR1physical
28514442
LRP6_HUMANLRP6physical
28514442
LRP5_HUMANLRP5physical
28514442
CA2D2_HUMANCACNA2D2physical
28514442
FPRP_HUMANPTGFRNphysical
28514442
NDST2_HUMANNDST2physical
28514442
PLXA1_HUMANPLXNA1physical
28514442
PLTP_HUMANPLTPphysical
28514442
MET_HUMANMETphysical
28514442
NHLC3_HUMANNHLRC3physical
28514442
SORL_HUMANSORL1physical
28514442
FRAS1_HUMANFRAS1physical
28514442
EOGT_HUMANEOGTphysical
28514442
F234B_HUMANKIAA1467physical
28514442
ENTP7_HUMANENTPD7physical
28514442
TXD16_HUMANTXNDC16physical
28514442
GRP78_HUMANHSPA5physical
28514442
FCGRN_HUMANFCGRTphysical
28514442
F234A_HUMANITFG3physical
28514442
WDR54_HUMANWDR54physical
28514442
PLXB2_HUMANPLXNB2physical
28514442
OSTM1_HUMANOSTM1physical
28514442
ARSA_HUMANARSAphysical
28514442
CHSTA_HUMANCHST10physical
28514442
MRC2_HUMANMRC2physical
28514442
SCRB2_HUMANSCARB2physical
28514442
LCAP_HUMANLNPEPphysical
28514442
CAHD1_HUMANCACHD1physical
28514442
PTPRU_HUMANPTPRUphysical
28514442
EMC4_HUMANEMC4physical
28514442

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SG1D1_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP